Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three versus seven days of antibiotic therapy for mild leptospirosis in French overseas departments
2024-518027-30-00Phase 2Authorised
- Sponsor
- CHU de Martinique
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of doxycycline, amoxicillin and ceftriaxone in leptospirosis (2 arms), sponsored by CHU de Martinique. Primary endpoints: Treatment failure at 7 days (complications), Hemodynamic failure and 11 more. Planned start Aug 2026; status: authorised.
02
Drugs
doxycyclineamoxicillinceftriaxone
03
Conditions
leptospirosis
Beyond the preview
Go deeper on 2024-518027-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518027-30-00.